Identiv(US:INVE)2025-08-07 21:00Financial Performance - Net revenue decreased from $6.7 million in Q2 2024 to $5.0 million in Q2 2025 due to the planned exit of low margin business[12] - GAAP gross margin decreased from 9.1% in Q2 2024 to -9.4% in Q2 2025, while non-GAAP gross margin decreased from 14.6% to -0.8% due to Thailand to Singapore transition and lower utilization[12] - GAAP net loss from continuing operations decreased from ($6.9 million) in Q2 2024 to ($6.0 million) in Q2 2025, with EPS from continuing operations (GAAP) diluted improving from ($0.31) to ($0.26)[12] - Non-GAAP adjusted EBITDA decreased from ($3.7 million) in Q2 2024 to ($4.6 million) in Q2 2025 due to additional costs related to the completion of production in Singapore[12] Balance Sheet and Cash Flow - Cash and cash equivalents decreased from $132.7 million in Q1 2025 to $129.6 million in Q2 2025[13] - Net operating cash use for the 9 months following Sept 30, 2024, was $10.3 million, with an expected net operating cash use of $13 million to $15 million for the 12 months following Sept 30, 2024[13, 14] Business Updates and Outlook - The company anticipates continued market uncertainty and is closely monitoring risks, having developed a pass-through strategy to protect margins[7] - Q3 2025 net revenue is expected to be $4.8 million to $5.2 million, impacted by a 19% tariff on imports from Thailand announced by the U S government in July 2025[15] - The company is executing its "Perform, Accelerate, and Transform" (P-A-T) strategy to grow sales and EBITDA[19] - The company has 100 "new" sales opportunities in the pipeline at the end of Q2 2025, with a 14% conversion rate to sales during the first half of 2025[37] - There are 19 active new product development (NPD) projects at the end of Q2 2025, including 12 customer-driven and 7 internally-driven projects[37]